Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibi...See more
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2017 (8 years)
Address:
1065 E HILLSDALE BLVD; SUITE 100; FOSTER CITY, CALIFORNIA 94404, US
At a glanceHIGH
spending power
